IL-23 produced by activated macrophages induces IL-17 production from γδT cells and causes further ischemic damage during the delayed phase of brain ischemia [33], while CD14highCD16+ intermediate Mo were reported to promote Th17 responses in rheumatoid arthritis [34]. Here, IL17A is linked to rheumatoid arthritis.